Short answer: neither Semax nor Selank is a licensed medicine in the UK, as far as we are aware, and that single fact is what most “is Semax legal in the UK” searches are really about. Whether a particular act involving them is lawful depends on how the material is presented, supplied and intended to be used, which is a matter of medicines law that we cannot settle in one word. On the second question, the published pharmacology describes Semax as a neuropeptide that influences neurotrophin and monoamine systems in animals, which is not the same thing as a classical stimulant. This guide explains both questions with the evidence we can verify. It is educational, it is not legal advice, and Peptides Lab UK supplies these peptides for laboratory research only.
What Semax and Selank are
Both are short synthetic peptides developed in Russia, at the Institute of Molecular Genetics of the Russian Academy of Sciences, and both have been used as medicinal products there. They are related by a shared design idea, which is to attach the Pro-Gly-Pro tripeptide to a fragment of a naturally occurring peptide in order to slow its breakdown.
- Semax is Met-Glu-His-Phe-Pro-Gly-Pro. It is built from the ACTH(4–10) fragment of adrenocorticotropic hormone, extended with Pro-Gly-Pro. Crucially, it lacks the hormonal activity of ACTH. Our guides to Semax and to its structural cousin Adamax describe how the sequence has been modified further.
- Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is built from tuftsin, a tetrapeptide fragment of immunoglobulin G, again extended with Pro-Gly-Pro. See our Selank guide.
Both are covered in the longer comparison, Selank versus Semax. This article focuses on the two questions that dominate search results.
Is Semax legal in the UK?
“Legal” is a short word for a long question. A fair answer has three parts.
First, licensing. To our knowledge, neither Semax nor Selank holds a UK marketing authorisation. A product that is not licensed cannot be lawfully marketed in the UK as a medicine for people. In Russia, by contrast, these peptides have been developed and authorised as medicines, which is the source of many claims in online discussion. A licence in one country does not carry over to another.
Second, how a product is classed. Under UK medicines legislation, a product can be treated as a medicinal product because of what it is claimed to do or how it is presented, not only because of what it contains. That is why suppliers of research materials label them for laboratory use only, and why that label alone does not settle the status of a given product or act. Current guidance is published by the MHRA.
Third, other rules. Other legislation, for example on psychoactive substances or on supply, can also be relevant depending on the substance and the circumstances. We do not apply them to a single product in this article, because the correct answer depends on facts that a blog cannot know.
Put simply: “unlicensed in the UK” is a reasonably safe statement, “perfectly legal” and “illegal” are both statements that need legal advice behind them. Searches like “is Semax illegal in the UK” and “is Selank legal in the UK” cannot be answered with a yes or a no by a laboratory supplier. If it matters for your situation, take qualified legal advice and follow your institution’s rules.
Is Semax a stimulant?
The question usually comes from people who have heard Semax described as a “nootropic” and wonder if it behaves like caffeine or an amphetamine-type drug. The published literature suggests a different picture, though it is mostly animal work.
Eremin et al. (Neurochemical Research, 2005) reported that Semax, an ACTH(4–10) analogue with nootropic properties, activated dopaminergic and serotoninergic brain systems in rodents. That is a statement about neurochemical markers in animals. It is not the same as saying that Semax produces a stimulant effect in people, and it does not describe the profile of classical stimulants, which act directly on monoamine transporters or release.
A second strand concerns neurotrophins. Dolotov et al. (Brain Research, 2006) reported that Semax regulated BDNF and trkB expression in the rat hippocampus. Brain-derived neurotrophic factor signalling is of interest in learning, plasticity and neuroprotection research. It is an important distinction that BDNF regulation is a longer-timescale, gene-expression-level effect, which is conceptually different from the acute pharmacology of a stimulant.
The honest summary is therefore:
- What is published: changes in monoamine systems and in BDNF and trkB expression in rodents.
- What is not established: a stimulant-like profile in people, or that these animal findings translate to people at all.
- What remains open: how much of Semax’s reported activity depends on the route and formulation used in the original work, which differs from a laboratory vial.
Questions such as “is Semax used for ADHD” are also common. We are not aware of high-quality, independently replicated controlled trials that would justify a claim of that kind under UK standards, and this guide does not attempt to review the Russian-language clinical literature. Semax is not authorised in the UK for that or any other indication.
What about Selank?
Selank is usually discussed in terms of anxiolytic-type and immunomodulatory research rather than stimulation. Volkova et al. (Frontiers in Pharmacology, 2016) reported that Selank administration affected the expression of some genes involved in GABAergic neurotransmission, which is one reason it is studied in neuropharmacology. As with Semax, this is a gene-expression finding in an experimental system and not a statement about effects in people.
The question “is Selank safe to take” is another human-use question that a laboratory supplier cannot answer. The relevant fact is that safety in a licensed-medicine sense depends on regulatory evaluation of a defined product, and that has not occurred in the UK. Our research-oriented overviews of Semax safety in research and Selank safety in research describe the reported laboratory findings.
The clinical study that is usually cited
If Semax has a human-data anchor, it is the work on ischaemic stroke. Khomenko et al. (2018) reported a study in patients with ischaemic stroke in which Semax administration was associated with higher plasma BDNF levels and with Barthel index scores. It is a stroke study with a specific protocol and a specific population. It does not make Semax a general-purpose cognitive aid, and it says nothing about unlicensed use in healthy people. Our product page for Semax for laboratory research carries the same limits on interpretation.
Practical points for laboratories
- Identify the molecule by sequence. Semax and its analogues, including N-acetylated and adamantylated variants, behave differently. Specify the exact sequence in the protocol.
- Verify the batch. A certificate with HPLC and mass-spectrometry data, matched to the batch number on the vial, is the minimum. Batches from Peptides Lab UK are HPLC & COA Verified.
- Plan concentrations by calculation. The peptide calculator handles mass-to-concentration conversions for laboratory dilutions.
- Keep records. Store material as the certificate states and log its use, which also helps if an institutional or regulatory question arises.
For the equivalent Selank material, see the Selank product page.
A note on the word “nootropic”
Much of the confusion around Semax comes from the label. “Nootropic” was coined by the chemist Corneliu Giurgea in the early 1970s for substances thought to enhance learning and memory without the side effects of stimulants or sedatives. The word has since drifted into marketing, where it is applied to anything from caffeine to experimental peptides. A label of that kind carries no regulatory or pharmacological meaning. It does not tell you the mechanism, the evidence base or the legal status of a compound, and a researcher should replace it with specifics: which receptors, which pathways, in which species and under which conditions.
Frequently asked questions
If you are weighing UK peptides suppliers, our guide to buying peptides in the UK and the best research peptides UK scorecard explain what documentation to look for.
Is Semax legal in the UK?
To our knowledge Semax holds no UK marketing authorisation, so it cannot be lawfully marketed as a medicine for people. Whether a particular act is lawful depends on presentation, supply and intended use, so take qualified legal advice. Peptides Lab UK supplies it for laboratory research only.
Is Semax illegal in the UK?
That cannot be answered with a plain yes or no. It is unlicensed as a medicine in the UK, and other rules may apply depending on the circumstances. This is not legal advice.
Is Semax a stimulant?
Published animal work reports effects on dopaminergic and serotoninergic markers and on BDNF and trkB expression. That is not the same as a classical stimulant, and no study we can cite establishes a stimulant-like effect in people.
Is Selank legal in the UK?
As with Semax, Selank is not a UK-licensed medicine to our knowledge, and the lawfulness of any specific act depends on the circumstances. It is supplied by Peptides Lab UK for laboratory research only.
Is Semax used for ADHD?
Semax is not authorised in the UK for ADHD or any other indication, and we are not aware of independently replicated, high-quality controlled trials that would support such a claim under UK standards.
Peptides Lab UK products are supplied for laboratory research use only, not for human or veterinary use. This article is educational and is not legal or medical advice.